What is the official price guide for cemiplimab?

Cemiplimab (Cemiplimab) is a PD-1 inhibitor mainly used to treat cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC) and non-small cell lung cancer (NSCLC). The drug enhances the anti-tumor response of the immune system by inhibiting the PD-1 receptor, thereby effectively treating certain malignant tumors. Cimepilimab has been approved in many countries and regions and has a certain influence in the international market. However, in China, the official price guidance for cimepilimab remains unclear.

The original drug of cimepilimab has not yet been launched in China, so domestic price information is not public. As for the price in overseas markets, cimepilimab is mainly produced by Regeneron Pharmaceuticals and is already available in the United States and Europe. In the United States, the common specification of cimepilimab is 350mg/7mL (50mg/mL), and the price of each box is generally between RMB 40,000 and RMB 100,000. Specific price fluctuations are related to exchange rate changes and pricing strategies in different regions, so selling prices may vary globally.

It is worth noting that cimepilimab has not yet entered the scope of medical insurance in China, which means that patients who need to use this drug will face higher treatment costs. Since drug prices vary in different countries and regions, their international pricing is mainly determined by factors such as market demand, production costs, government pricing policies, and medical insurance policies.

Although cimepilimab is not currently available in the Chinese market, as the clinical application of this drug gradually deepens, it is expected that it may enter the Chinese market and be included in the scope of medical insurance in the future. This will make the use of medicines more popular and the burden on patients is expected to be further reduced.

In summary, the price of cimepilimab is affected by multiple factors, including production costs, exchange rate fluctuations, and pricing policies in various regions. At present, in overseas markets, its price is roughly between 40,000 and 100,000 yuan, while in the Chinese market, its price has not been clearly disclosed.

Reference materials:https://www.libtayohcp.com/